Mary Beth Nierengarten

Tofacitinib Monotherapy Offers Significant Benefits for Active RA

02/19/2014

San Diego—In patients with rheumatoid arthritis (RA), tofacitinib monotherapy significantly inhibits progression of structural damage, improves signs and symptoms of disease, and improves function over 2 years compared to patients treated...

San Diego—In patients with...

02/19/2014

First Report Managed Care

Drug-Eluting Stents versus Bare-Metal Stents in PCI

08/15/2012

Mary Beth Nierengarten ;

Results of a pooled patient-level meta-analysis [Arch Intern Med. 2012;172(8):611-621] comparing drug-eluting stents (DES) to bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary...

Results of a pooled...

08/15/2012

First Report Managed Care

Conference Insider

Optimizing Clinical and Cost Outcomes for Managing Rheumatoid Arthritis

06/10/2015

Mary Beth Nierengarten ;

Spending on specialty drugs is growing rapidly in the United States, with an increasing amount of spend shifting to the pharmacy benefit.

Spending on specialty drugs is...

06/10/2015

First Report Managed Care

Feature

COVID-19 Urges Attention to Health Equity

05/28/2021

Mary Beth Nierengarten ;

On January 21, 2021, President Biden issued an executive order “Ensuring an Equitable Pandemic Response and Recovery” in which he established the COVID-19 Health Equity Task Force, charged with providing specific recommendations for...

On January 21, 2021, President...

05/28/2021

First Report Managed Care

Ensuring Access to Primary Care for Medicare Beneficiaries

08/26/2019

Mary Beth Nierengarten ;

The June MEDPAC report outlines areas where improvement is needed, emphasizing the importance of Medicare beneficiaries’ access to primary care and increasing incentive for medical students to choose primary care as a career choice.

The June MEDPAC report outlines...

08/26/2019

First Report Managed Care

Emerging Evidence and Future Direction of Chemoprevention in Pancreatic Cancer

07/30/2015

Mary Beth Nierengarten ;

Chemoprevention is used to target populations with preneoplastic lesions such as ductal in situ carcinoma and familial adenomatous polyposis.

Chemoprevention is used to...

07/30/2015

First Report Managed Care

Advanced Treatment Options for Men with Low-Risk Prostate Cancer

09/19/2013

Mary Beth Nierengarten ;

Results of a retrospective cohort study show that the use of advanced treatment technologies for men with prostate cancer with low-risk disease, those at high risk of noncancer mortality, or men with both low-risk disease and at high risk of...

Results of a retrospective...

09/19/2013

First Report Managed Care

Cardiovascular Risk in Patients with Rheumatoid Arthritis

03/16/2012

Mary Beth Nierengarten ;

Chicago—In patients with rheumatoid arthritis (RA), the length of disease duration does not appear to aggravate or contribute to cardiovascular risk, but very low disease activity sustained over time may actually have a beneficial effect on...

Chicago—In patients with...

03/16/2012

First Report Managed Care

Conference Insider

Ustekinumab for Patients with Active PsA Long-Term

02/19/2014

Mary Beth Nierengarten ;

San Diego—The efficacy and safety of ustekinumab as treatment for active psoriatic arthritis (PsA) is maintained at 100 weeks follow-up, according to long-term data presented at the ACR/ARHP meeting.

San Diego—The efficacy and...

02/19/2014

First Report Managed Care

Feature

Countering Misinformation in Medicine

05/20/2022

Mary Beth Nierengarten ;

Medical misinformation is a growing challenge throughout health care, exacerbated by the ubiquitous use of social media that reinforces people’s tendencies to perceive and believe in things supported by other people.

Medical misinformation is a...

05/20/2022

First Report Managed Care